OpenLoop CMO Reveals 3 Trends That Defined HLTH 2025

The views expressed below are Dr. Mohit Joshipura’s personal opinions and observations from HLTH 2025. The content is informational and not medical advice.

At HLTH 2025, the pulse of the digital health industry was unmistakable: we’ve entered a new era of maturity. Technologies that once felt revolutionary—AI, GLP-1 therapies, remote monitoring—are now part of everyday conversation.

But as Dr. Mohit Joshipura, Chief Medical Officer at OpenLoop Health, reflected, the questions being asked are evolving: How do we make these innovations sustainable? How do we integrate them into real-world care models?

Here are his three biggest takeaways from HLTH 2025—and what they mean for the next chapter of digital health.

1. AI Has Become Table Stakes — It’s All About Integration Now

“Every booth had ‘AI’ on it,” Dr. Joshipura said. “But it’s no longer enough to just have AI—it has to drive measurable value.”

Just one year ago, AI dominated HLTH conversations as the shiny new object. This year, it was clear: AI isn’t the differentiator anymore—it’s the baseline. The conversation has shifted from what AI can do to how it fits into care delivery and operations.

Organizations that stand out are those embedding AI seamlessly into their workflows—from patient triage to documentation to predictive analytics—rather than using it as a standalone point solution.

The real winners will be those who use AI to enhance human intelligence, not replace it. “AI isn’t the headline anymore,” Joshipura noted. “It’s the infrastructure—the invisible backbone improving speed, safety, and scale.”

As digital health companies mature, AI’s value will be measured less by novelty and more by ROI, outcomes, and patient trust. The question isn’t “Do you have AI?” anymore. It’s “Is your AI making care smarter, safer, and more human?”

2. GLP-1s and the Push for Sustainable, Accessible Weight Management

“The conversation around GLP-1s evolved from excitement about the drugs themselves to how we build sustainable access and care models,” said Dr. Joshipura.

Last year, GLP-1 medications dominated headlines as breakthrough weight-loss therapies. This year, the industry’s focus matured—from enthusiasm to execution.

HLTH 2025 sessions centered on three interlocking challenges:

• Access — How do we ensure coverage for patients across demographics and payer types?

• Sustainability — What happens when patients stop therapy?

• Comprehensive Care — How do we wrap behavioral, nutritional, and fitness support around pharmacotherapy?

Dr. Joshipura emphasized that while GLP-1s are “an incredibly powerful tool,” they cannot be the only tool. “The science is clear—when people discontinue therapy, most regain weight. That means success requires a full-circle model: medication, lifestyle, and mental health working together.”

He also pointed to oral GLP-1s as a coming inflection point. Lower barriers to access could reshape obesity care and bring these therapies to broader populations, but only if healthcare systems are ready to manage them sustainably.

“We can’t have arbitrary hard stops on coverage,” he added. “We need care models built for the long game—because obesity is a chronic condition, not a temporary state.”

3. The Rise of Wearables and Remote Patient Monitoring (RPM)

“As GLP-1s transform metabolic health, the demand for remote insights has skyrocketed,” Dr. Joshipura shared. “Patients, providers, and payers all want to see progress in real time.”

The growing adoption of GLP-1s and cardiometabolic care programs has naturally accelerated interest in wearables and remote patient monitoring (RPM). HLTH 2025 featured dozens of conversations on how connected devices are redefining care—not just for high-risk patients, but across the full wellness spectrum.

Modern RPM tools are delivering more accurate, clinically actionable data than ever before—tracking everything from blood sugar to sleep to heart rate variability. For providers, that means earlier intervention. For payers, it means clearer outcomes data. For patients, it means a sense of agency in their own care.

Dr. Joshipura described this as a pivotal shift from episodic to continuous care.

“As people gain access to therapies that can transform their metabolic health, it’s only natural they—and their care teams—want deeper visibility into how those therapies are working. That’s what wearables and RPM make possible.”

The intersection of pharmacotherapy and real-time monitoring is ushering in an era of proactive, preventive, data-rich care that benefits everyone across the ecosystem.

From Buzzword to Scalable, Sustainable Care

From AI integration to sustainable obesity care and next-generation remote monitoring, HLTH 2025 marked a clear turning point. The future of healthcare isn’t about chasing the next new technology—it’s about connecting the right technologies in service of better care.

“Digital health has moved from novelty to necessity,” Dr. Joshipura reflected. “Now, the challenge is building systems that make it scalable, sustainable, and deeply human.”

Ready to take that step toward a more modern healthcare solution? Learn how OpenLoop’s white-label infrastructure solutions and 50-state PC network can launch you into the future.

*This content is intended for general informational purposes only and should not be construed as legal advice. For guidance on your specific situation, please consult a licensed attorney.